These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20877211)

  • 1. A therapeutic approach to nasopharyngeal carcinomas by DNAzymes targeting EBV LMP-1 gene.
    Yang L; Lu Z; Ma X; Cao Y; Sun LQ
    Molecules; 2010 Sep; 15(9):6127-39. PubMed ID: 20877211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma.
    Lu ZX; Ma XQ; Yang LF; Wang ZL; Zeng L; Li ZJ; Li XN; Tang M; Yi W; Gong JP; Sun LQ; Cao Y
    Cancer Lett; 2008 Jul; 265(2):226-38. PubMed ID: 18353539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma.
    Yang L; Liu L; Xu Z; Liao W; Feng D; Dong X; Xu S; Xiao L; Lu J; Luo X; Tang M; Bode AM; Dong Z; Sun L; Cao Y
    Oncotarget; 2015 Mar; 6(8):5804-17. PubMed ID: 25714020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis.
    Lu ZX; Ye M; Yan GR; Li Q; Tang M; Lee LM; Sun LQ; Cao Y
    Cancer Gene Ther; 2005 Jul; 12(7):647-54. PubMed ID: 15803142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence visualization screening for EBV-LMP1-targeted DNAzymes.
    You X; Yang YC; Ke X; Hong SL; Hu GH
    Otolaryngol Head Neck Surg; 2014 Feb; 150(2):251-8. PubMed ID: 24323909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity.
    Yang L; Xu Z; Liu L; Luo X; Lu J; Sun L; Cao Y
    Cancer Biol Ther; 2014 Jan; 15(1):61-8. PubMed ID: 24145206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
    Wasil LR; Wei L; Chang C; Lan L; Shair KH
    J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-κB regulated ATM expression.
    Ma X; Yang L; Xiao L; Tang M; Liu L; Li Z; Deng M; Sun L; Cao Y
    PLoS One; 2011; 6(11):e24647. PubMed ID: 22096476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of LMP1 protein expression by EBV-encoded microRNAs.
    Lo AK; To KF; Lo KW; Lung RW; Hui JW; Liao G; Hayward SD
    Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16164-9. PubMed ID: 17911266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas.
    Cao Y; Yang L; Jiang W; Wang X; Liao W; Tan G; Liao Y; Qiu Y; Feng D; Tang F; Hou BL; Zhang L; Fu J; He F; Liu X; Jiang W; Yang T; Sun LQ
    Mol Ther; 2014 Feb; 22(2):371-377. PubMed ID: 24322331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model.
    Ke X; Yang YC; Hong SL
    Med Oncol; 2011 Dec; 28 Suppl 1():S326-32. PubMed ID: 20862567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas.
    Liao WH; Yang LF; Liu XY; Zhou GF; Jiang WZ; Hou BL; Sun LQ; Cao Y; Wang XY
    BMC Cancer; 2014 Nov; 14():835. PubMed ID: 25407966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anoikis resistance and immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1α promotes invasion and metastasis of nasopharyngeal carcinoma.
    Liao C; Li M; Chen X; Tang C; Quan J; Bode AM; Cao Y; Luo X
    J Exp Clin Cancer Res; 2023 Oct; 42(1):261. PubMed ID: 37803433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
    Zheng H; Li LL; Hu DS; Deng XY; Cao Y
    Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.
    Chang PY; Wu ZZ; Sun NK; Chao CC
    J Cell Physiol; 2014 Mar; 229(3):309-22. PubMed ID: 23939952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways.
    Zhang J; Jia L; Lin W; Yip YL; Lo KW; Lau VMY; Zhu D; Tsang CM; Zhou Y; Deng W; Lung HL; Lung ML; Cheung LM; Tsao SW
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.
    Xiao L; Hu ZY; Dong X; Tan Z; Li W; Tang M; Chen L; Yang L; Tao Y; Jiang Y; Li J; Yi B; Li B; Fan S; You S; Deng X; Hu F; Feng L; Bode AM; Dong Z; Sun LQ; Cao Y
    Oncogene; 2014 Sep; 33(37):4568-78. PubMed ID: 24662831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.